Navigation Links
Qforma Appoints Four Executives in Sales and Field Operations
Date:6/25/2009

SANTA FE, N.M., June 25 /PRNewswire/ -- Qforma, an advanced analytics and predictive modeling company, today announced the appointments of four executives to sales and field operations positions: Mark J. Grove is appointed Senior Vice President, Sales, New Business; Dean H. Kleyn advances within Qforma from Director, Field Operations to Vice President, Sales and Services; and Rod Anaforian and Kim Foster join Qforma as Directors, Field Operations.

These appointments follow a series of important milestones for Qforma in 2009, highlighted by the launch in May of the "Most Influential Doctors" (MID) database, a new quarterly health feature developed by Qforma and presented by USA TODAY that for the first time provides consumers with access to valuable information about the top healthcare providers in virtually every U.S. metropolitan area.

"This is an exciting, transformational time for Qforma and we are pleased with our continued growth and the increased interest in our technology, products and expertise," said Kelly D. Myers, CEO of Qforma. "Most of all we are proud of the high caliber of professionalism that Qforma is able to bring to our customers, as represented by these four experienced and extremely talented individuals."

Mark J. Grove has held multiple sales positions over the course of his career in the healthcare industry, with a proven record of exceeding goals and advancing to positions of increasing responsibility at such companies as Tyco International, IMS Health, and Concord Management Group. He most recently served as Executive Vice President at Healthy Advice Networks.

Dean H. Kleyn brings to his new position within Qforma more than 15 years of sales, data integrity, advanced analytics, market research and software services experience in the pharmaceutical and biotech industries, enhanced by several years in the health care financing sector.

Ro
'/>"/>

SOURCE Qforma
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Qforma Appoints Two New Executives
2. BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance
3. Codexis Appoints Singapore Laboratories Managing Director
4. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
5. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
6. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
7. NanoLogix Inc. Appoints Director of IP and Makes Progress on Rapid Anthrax Detection
8. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
9. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
10. NeurogesX Appoints New Director to the Board
11. Alba Therapeutics Appoints Dr. Betsy Van Parijs as Its Senior Vice President, Clinical Development and Medical Affairs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 2015  Derma Sciences, Inc. (Nasdaq: DSCI ... wound care, announces that AMNIOEXCEL® and AMNIOMATRIX®, amniotic ... to the Premier, Inc. Regenerative Skin Grafting contract ... AMNIOEXCEL® and AMNIOMATRIX® product lines, which continue to ...
(Date:12/24/2014)... Texas , Dec. 24, 2014  Vermillion, Inc. ... on gynecologic disease, announced today that the Company ... including Oracle Investment Management, Jack W. Schuler ... Total proceeds were $10.5 million, before offering expenses.  ...
(Date:12/24/2014)... 2014 Earlier this year in a June ... the Adult Stem Cell Technology Center, LLC ( ASCTC ) ... property of adult tissue stem cells. His title “Asymmetric ... for the Future,” embodied the essence of his message to ...
(Date:12/24/2014)... (PRWEB) December 23, 2014 The ... as its definition, classification, application and industry overview. ... and product cost structure. Production is separated by ... upstream raw materials, equipment, downstream client survey, marketing ...
Breaking Biology Technology:Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4Worldwide Methyl Mercaptan Market 2015-2020 Forecasts on Development & Trends Now Available at ReportsnReports.com 2
... , TOKYO, Japan, August 3 ... June 30, 2009. Net,sales were 94.9 billion yen for the ... period last year, and operating income was 9.2,billion yen, a ... last,year, mainly due to order decrease and the impact of ...
... ... Global Jatropha Hi-Tech Agricultural Training Programme (JWTP) in India from October 6-10, ... Development of Sustainable Non-Food Jatropha and other Oil Crop Projects, Programmes and ... lot of milestones since last year,s event, and a number of alternative ...
... , , , , ... Calif., Aug. 2 Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, ... exclusive license and collaboration agreement to commercialize Intermezzo ((R)) (zolpidem ... U.S. Food and Drug Administration (FDA), Intermezzo ((R)) has the ...
Cached Biology Technology:Hoya Announces First Quarter Financial Results for FY2010 2Global Jatropha Hi-Tech Agricultural Training Programme (JWTP) 2Global Jatropha Hi-Tech Agricultural Training Programme (JWTP) 3Global Jatropha Hi-Tech Agricultural Training Programme (JWTP) 4Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo(R) in the United States 2Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo(R) in the United States 3Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo(R) in the United States 4Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo(R) in the United States 5Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo(R) in the United States 6Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo(R) in the United States 7
(Date:12/15/2014)... Markets ( http://www.researchandmarkets.com/research/87pph8/global_facial ) has announced the ... report to their offering. ... technology used for the identification of individuals. Facial recognition ... such as nose, jaw edges, mouth, and the distance ...
(Date:12/11/2014)... N.C. , Dec. 10, 2014  That blood pressure plays ... a while. Hypertension – the medical term for high blood ... early 1800s, and the inflatable cuff that,s used in measuring ... however, mean there,s nothing new about hypertension, its triggers and ...
(Date:12/10/2014)... N.C. , Dec. 9, 2014  Valencell, a leader ... is seeing a staggering demand from its licensees for ... Company revealed, is not solely coming from fitness and ... well. "A wearable is only as useful ...
Breaking Biology News(10 mins):Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Wearable Technology Products Demand Highly Accurate Biometric Technology 2
... percent of energy in the U.S. is produced by coal. ... A professor in the College of Engineering at the ... Department of Energy to help change that. ... Materials Science and Engineering, and colleagues have received a $300,000 ...
... ,PROVIDENCE, R.I. [Brown University] Selenium is an inexpensive ... also known to combat bacteria. Still, it had not ... device material. In a new study, Brown University engineers ... polycarbonate, the material of catheters and endotracheal tubes, the ...
... messages, from bananas to home-grown tomatoes: everything we buy, produce or ... a "footprint". And if you want to be a good global ... use to understand just how big your footprint is or ... But what if you are a government decision maker and want ...
Cached Biology News:University of Tennessee professor receives funding for clean coal research 2Selenium suppresses staph on implant material 2Selenium suppresses staph on implant material 3A virtual crystal ball 2A virtual crystal ball 3A virtual crystal ball 4
... Detection System combines the indirect labeling ... and Signets unique formulation of ultra ... reliablility. Signet reagents will achieve excellent ... automated protocols. ,Signets USA Detection ...
6X Loading Buffer is intended for gel electrophoresis of DNA fragments or PCR products....
6X DNA Gel Loading Buffer is intended for gel electrophoresis of DNA fragments or PCR products....
Makes gels easy to load and track during electrophoresis. 10X concentrate of Bromophenol Blue, Xylene Cyanol, glycerol solution in TE...
Biology Products: